J.A. Levi
- Genetics top 5%
-
- Sarcoma Diagnosis and Treatment 3
- Brain Metastases and Treatment 2
- Oncology top 10%
- Lung Cancer Research Studies 4
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 3
- Neurology top 10%
-
- Testicular diseases and treatments 4
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
-
- Neuroendocrine Tumor Research Advances 2
-
- Cancer therapeutics and mechanisms 1
- Co-authors
- David BellR. N. HITCHINSR. WoodsDerek RaghavanVJ HarveyD. DalleyR. S. AroneyWing‐Kai Chan
- Journals
- Journal of Clinical Oncology (2 papers)The Lancet (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- AustraliaNew ZealandBelgium
In The Last Decade
J.A. Levi
13 papers receiving 648 citations
Peers
Comparison fields: 5 of 59
- Genetics 192
- Pulmonary and Respiratory Medicine 408
- Oncology 281
- Reproductive Medicine 66
- Neurology 106
Countries citing papers authored by J.A. Levi
This map shows the geographic impact of J.A. Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Levi more than expected).
Fields of papers citing papers by J.A. Levi
This network shows the impact of papers produced by J.A. Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Levi. The network helps show where J.A. Levi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J.A. Levi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 75 | |
| 2 | A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand. | 1997 | 9 |
| 3 | 1996 | 42 | |
| 4 | 1993 | 102 | |
| 5 | Ifosfamide combination regimens for soft-tissue sarcoma. | 1993 | 6 |
| 6 | 1989 | 16 | |
| 7 | 1989 | 7 | |
| 8 | 1988 | 5 | |
| 9 | 1988 | 65 | |
| 10 | 1987 | 270 | |
| 11 | 1985 | 4 | |
| 12 | 1983 | 7 | |
| 13 | 1981 | 68 |
About J.A. Levi
J.A. Levi is a scholar working on Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine, Surgery and Hepatology, having authored 13 papers that have together received 676 indexed citations. Recurring topics across this work include Testicular diseases and treatments (4 papers), Lung Cancer Research Studies (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Brain Metastases and Treatment (2 papers) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Genetics (192 citations), Pulmonary and Respiratory Medicine (408 citations), Oncology (281 citations), Reproductive Medicine (66 citations) and Neurology (106 citations). J.A. Levi has collaborated with scholars based in Australia, New Zealand and Belgium. Frequent co-authors include David Bell, R. N. HITCHINS, R. Woods, Derek Raghavan, VJ Harvey, D. Dalley, R. S. Aroney, Wing‐Kai Chan, Robert L. Woods and Z. Kerestes. Their work appears in journals such as Journal of Clinical Oncology, The Lancet, European Journal of Cancer, Gynecologic Oncology and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.